← 返回

γδ T 细胞在癌症中的多样作用:从快速免疫到侵袭性淋巴瘤

英文原题:The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma.

查看英文原题

The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma.

PubMed 2021/12/09(内容时间) Cancers (Basel) Q2 · IF 4.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

γδ T 细胞是塑造免疫反应中的独特参与者,位于固有免疫和适应性免疫的交汇处。与传统的 αβ T 细胞不同,γδ T 细胞主要分布于非淋巴外周组织,表现出组织特异性,并且它们以 MHC 非依赖的方式对配体作出反应。γδ T 细胞表现出快速激活和效应功能,具有细胞毒性抗肿瘤反应的能力以及产生如 IFN-γ 或 IL-17 等炎性细胞因子的能力。它们快速的细胞毒性特性使其成为抗癌免疫治疗中有吸引力的细胞。

然而,在发生转化后,γδ T 细胞可产生高度侵袭性的淋巴瘤。这些罕见的恶性肿瘤往往患者生存率低,且尚无治愈性疗法。在这篇综述中,我们讨论 γδ T 细胞在免疫监视和反应中的多样角色,特别关注癌症免疫。

我们总结了 γδ T 细胞在实体瘤和血液系统癌症中促肿瘤与抗肿瘤功能之间引人注目的二分性,突出涉及的关键亚群。最后,我们讨论 γδ T 细胞转化的潜在驱动因素,总结主要的 γδ T 细胞淋巴瘤/白血病实体、其临床特征、在绘制其分子和基因组图谱方面的最新进展、当前治疗策略以及潜在的未来靶向选择。

展开英文摘要原文

γδ T cells are unique players in shaping immune responses, lying at the intersection between innate and adaptive immunity. Unlike conventional αβ T cells, γδ T cells largely populate non-lymphoid peripheral tissues, demonstrating tissue specificity, and they respond to ligands in an MHC-independent manner.

γδ T cells display rapid activation and effector functions, with a capacity for cytotoxic anti-tumour responses and production of inflammatory cytokines such as IFN-γ or IL-17. Their rapid cytotoxic nature makes them attractive cells for use in anti-cancer immunotherapies.

However, upon transformation, γδ T cells can give rise to highly aggressive lymphomas. These rare malignancies often display poor patient survival, and no curative therapies exist. In this review, we discuss the diverse roles of γδ T cells in immune surveillance and response, with a particular focus on cancer immunity.

We summarise the intriguing dichotomy between pro- and anti-tumour functions of γδ T cells in solid and haematological cancers, highlighting the key subsets involved.

Finally, we discuss potential drivers of γδ T-cell transformation, summarising the main γδ T-cell lymphoma/leukaemia entities, their clinical features, recent advances in mapping their molecular and genomic landscapes, current treatment strategies and potential future targeting options.

论文信息

作者
Schönefeldt S、Wais T、Herling M、Mustjoki S、Bekiaris V、Moriggl R、Neubauer HA
单位
Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.Austria
文献类型
综述
期刊
Cancers2021 Dec 9
原文标识
PubMed 34944832 · DOI 10.3390/cancers13246212